THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of […]